There seems to be 2 different timelines stated for ethics submission, in Q3 (as stated in the toxicology announcement) and h2cy2024 (as per company slides from May 2024 onwards) This seems a bit ambiguous to me and probably why there has been some talk or 'perception' of a delay. I cant find any where stated that the q3 timeline had changed?
Are you able to elaborate? Thank you
RAC Price at posting:
$1.79 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)